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Summary
Aims: The purpose of this paper is to highlight some of the benefits and challenges when undertaking research across several countries com-
prising diverse ethnic, lingual and historically different communities.
Methods: Literature review and experiences of the researchers who participated in the Students’ Health Inquiry, as regards the benefits and the 
challenges that can emerge when conducting collaborative research. The Delphi technique was employed to reach consensus on and prioritise 
the emerging challenges and suggested solutions.
Results: Challenges of research consortia include the preparatory work before the study, the ownership of the data and dissemination of results, 
as well as methodological, financial, operational, and structural challenges. These are described, each challenge is further broken down in its 
subcomponents, examples are given, and potential solutions are suggested.
Conclusions: If challenges can be prevented or solved, the benefits of research consortia include greater generalisability of findings, and more 
comprehensive understanding of the issues than would be possible with a single-site study. There is also an increased probability to bring about 
policy changes and programmatic adjustments. Cross-national research consortia can contribute to reduction in the inequality of resources and 
research opportunities in the collaborating countries. Research consortia deserve the attention of funding agencies. They are capable of bringing 
about synergies that result from working collaboratively together of large multi-disciplinary team of investigators who share their strengths, disciplines 
and expertise in order to bear on the same research issue in multiple countries and diverse populations.
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INTRoDUCTIoN
Research consortia that undertake cross-national research are 
becoming increasingly popular. A ‘research consortium’ is a group 
of individuals and their organisations working collaboratively 
together in order to attract funding and design and implement 
research over one or several countries and sites that would other-
wise be not achievable (1). Such consortia have proved to be ef-
fective in many clinical or epidemiologic investigations that span 
several countries or sites. They have pursued inquiries of student’s 
health behaviour (2), cancer prevention and control strategies (3), 
parenting practices (4), health care systems (5), or alternatively 
communicable diseases (6, 7), midwifery (8), partnership work-
ing (9) or quality-of-life research (10). In this paper, a research 
consortium undertaking international comparisons of the health of 
university students is employed as an example in order to illustrate 
a range of specific aspects that are associated with the cooperative 
nature of such projects. Whilst differences in mortality across 
European countries are well documented (11–14), the differences 
in somatic symptoms and psychosomatic health across Europe 
have received little attention (2). Hence there have been calls for 
comparisons of the health profiles among populations of young 
adults across several European countries (2, 15–17). 
University students constitute one group of young adults that 
is suitable for comparative investigations. Students are certainly 
accessible and are likely to participate in studies since many are 
aware of the importance of research. Moreover, as health and 
health behaviours are subject to demographic factors, the study 
of individual country effects can be better disentangled in a group 
characterised by restricted variations in terms of education, socio-
economic status, and age (2). Finally, students represent the future 
leaders of their countries and are often described as early adopters 
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and promoters of new behaviours. If they can be influenced to 
adopt healthier lifestyles, they might function as multipliers to 
their extended families and surrounding communities. Hence uni-
versity students are an appropriate sample for examining a range 
of risk taking and conversely, health promoting behaviours and for 
testing new and promissing health promotion programmes.
The purpose of this paper is to highlight some of the benefits 
and challenges encountered when undertaking research across 
several countries comprising diverse ethnic, lingual and histori-
cally different communities. The specific aims are: to describe 
a European consortium undertaking cross-national research on 
student health in several Western and Eastern European countries; 
to highlight some of the benefits of research consortia such as 
ours; to identify and illustrate the range of challenges associated 
with such consortia; and to suggest strategies on how to prevent/
overcome these challenges.
METHoDS
The idea of this paper was developed at a two day workshop 
funded by the German Academic Exchange Service (DAAD) 
with members of the Cross National Student Health Study Con-
sortium that was convened in Bielefeld in April 2006. The team 
members’ collective experiences range from collaborating with 
or managing such consortia, conducting research across several 
European countries or in their own countries, surveying student 
health behaviours across multiple institutions, faculties and col-
leges employing different languages, or alternatively building 
research partnerships with multiple and diverse communities 
(see 2, 9, 18–24). As such the group had previously dealt with 
many challenges related to a variety of features that confront 
multi-country research consortia. 
Hence, initial ‘brainstorming’ sessions were held with the 
members of the research consortium described in this paper 
(face-to-face discussions and subsequent e-mail and telephone 
communications). The purpose of the sessions was to explore the 
team members’ perceptions of the variety of challenges that they 
collectively faced when undertaking similar research across seven 
countries and to suggest possible solutions. After the preliminary 
‘brainstorming’ sessions were completed, the first author clustered 
the emerging themes and concerns into categories. Originally, 
there was an extended list of topics. These topics and clusters 
acted as an early working document that was then disseminated 
several times to the team members. The aim was to use the Delphi 
technique in order to distil the list by employing several rounds of 
refinements (25). The Delphi method is a group agreement method 
that was developed to identify goals and establish priorities on the 
basis of consensus and pooled judgement (26–28). However, in 
this review, the Delphi technique was somewhat customized (29), 
as the team members were not asked to rate the items and provide 
scores as in the classical procedure (30). Rather the aim was to 
highlight the issues that they felt were significant. Several rounds 
of alterations were undertaken, whereby the team participants 
were asked to respond to issues that emerged initially. After each 
round of fine tuning, topics were scrutinised, and subsequently 
eliminated from or added to the table anonymously in each stage 
of the inquiry. In this way, when no additional challenges were 
added, the more pertinent issues were progressively condensed 
and given attention while the less influential ones were progres-
sively abandoned in final version. When consensus was reached 
a literature review was undertaken in order to complement the 
emerging concerns with any other published challenges that were 
pertinent to the effective working of research consortia.
The topics that emerged included operational and structural 
challenges, as well as methodological and financial ones. The 
group also reported challenges that had to do with the prepara-
tory work that is required for European survey research. Finally 
the group had previously also dealt with the thorny issues of 
data ownership and authorship that confront such multi-country 
research consortia. These sets of challenges and possible solutions 
are addressed in this paper. 
DESCRIPTIoN oF THE CRoSS-NaTIoNal STUDENT 
HEalTH STUDY RESEaRCH CoNSoRTIUM 
Two initiatives inspired our research on students’ health. One 
was the Health-Behaviour in School-aged Children study (http://
www.hbsc.org). Another inspiration came from the existence of 
health centres at US American colleges and universities and their 
activities to influence students’ health-related lifestyle. The first 
study on students’ health and health behaviour at the University of 
Bielefeld was completed in 1996. The results of this survey were 
presented at European meetings (e.g. the conference of the Euro-
pean Public Health Association), which raised the interest of other 
researchers to conduct comparative studies at their institutions. 
The initial cross-national group consisted of four partners, and 
between 2000 and 2006 new researchers joined the consortium. 
Hence the research was being extended to more countries.
Table 1 depicts the current participating institutions and the 
sample sizes generated from each site. Between 1996 and 2006, 
universities from seven European countries had participated in 
the research. In three countries (Germany, Spain, and Lithuania), 
a second survey was undertaken about 3 or 4 years after the initial 
baseline survey, hence following up particular student cohorts with 
the same questionnaire. Such follow-ups are important in order to 
detect any trends in students’ risk-taking or health-conducive be-
haviours as well as their health promoting practices. Currently the 
consortium is establishing dialogues with new potential partners 
in order to expand the geographical regions that are participating 
in this research initiative. Such activities will be useful in generat-
ing larger datasets, which will reflect student health behaviours 
in more European countries. 
THE BENEFITS oF RESEaRCH CoNSoRTIa
Many benefits have been cited for research consortia (3, 31, 
32). Through their numerous investigative teams (5) and access 
to large and diverse sample populations (33), consortia like the 
one described in this paper are critical resources for exploring 
somatic symptoms and psychosomatic health and subsequently 
evaluating health promotion interventions. 
Research consortia spanning many countries have the advan-
tage of increased size and diversity of the potential study popu-
lation, as well as variation in their risk taking practices or risk 
averting lifestyles that are essential for the study of student health 
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behaviours. These variations that are characteristic of research that 
examines clusters of sites (34) ‘elevates the statistical power of 
the analyses and hence the validity and reliability of the findings’ 
(35). Besides larger sample sizes and better generalisability that is 
grounded in wider multi-country surveys, there is also extensive 
sharing of expertise and resources across the study teams, thereby 
exchanging valuable skills as well as minimising the duplication 
of studies (33). These and other benefits of cross-national research 
consortia are summarized in Table 2, including aspects of fund-
ing, synergy, dissemination and translation of research findings 
into health policy.
In sum, multi-country multi-centre research consortia offer 
several benefits in addressing key research questions about stu-
dent health that cannot be addressed in a single-site study. These 
include: (1) the maintenance of databases with a rich array of 
information on student health and risk taking behaviours, (2) 
economy of scale regarding the efforts required for health assess-
ment and health promotion activities, (3) a variety of structures 
and health policies that can promote or hinder health promotion 
at the university setting in different countries can be examined, 
and (4) epidemiologic comparisons among institutions, countries 
and student populations can be conducted. 
DISCUSSIoN oF RESEaRCH CoNSoRTIa: CHal-
lENGES, IMPlICaTIoNS aND PoSSIBlE SolU-
TIoNS
Table 3 outlines some of the challenges that could confront 
research consortia who are instigating or developing their research 
(and required funding), as well as their probable implications. It 
also illustrates the possible solutions that are essential in order 
that such consortia remain viable and relevant to the popula-
tions that they investigate and to the researchers who populate 
Table 1. Countries and institutions participating in the Cross-National Student Health Study between 1996 and 2006 
Country Institutions Sample size
Germany 1996 University of Bielefeld, Bielefeld 650
Germany 1998 (follow-up) University of Bielefeld, Bielefeld 163
Spain 1999 Navarra Public University, PamplonaUniversity of Alicante, Alicante
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527
Lithuania 2000
Kaunas University of Medicine 
Vytautas Magnus University 
Lithuanian University of Law 
Lithuanian Academy of Physical Education
Lithuanian University of Agriculture
Kaunas University of Technology
1031
Spain 2001 (follow-up) Navarra Public University, Pamplona 370
Turkey 2004 Hacettepe University, Ankara 1037
Lithuania 2004 (follow-up) Kaunas University, Kaunas 431
Poland 2005 Catholic University of Lublin, Lublin 591
Bulgaria 2005 Sofia University, Sofia 709
Denmark 2005 University of Southern Denmark, Esbjerg 548
Germany 2005 University of Bielefeld, Bielefeld 803
Table 2. Benefits of collaborative European research consortia
Benefit Example
Scientific gains Increased size and diversity of the study population, variations in risk taking practices or risk averting life styles,  and variations in health policies and structural settings contribute to better understanding of issues.
Expertise of investigator team Investigators complement each other due to multiple theoretical approaches, disciplines, educational backgrounds  and strengths. 
Funding Specific funding mechanisms are available for Europeanwide research consortia that are not open for individual  studies. 
Generalisability Larger sample size, multiple countries, settings, health strategies and social environments increase generalisability. 
Synergy
Sharing of expertise and resources. Lessons learned in one country may be applicable to other countries. Instead  
of developing interventions de novo for the same health problem in each country, investigators may be able to adapt 
an intervention that was successful in one country to another setting.
Determining environmental/ social 
influences
Studying similar populations and interventions in different countries can examine the impact of environmental factors 
(e.g. health policy or culture) and social influences (e.g. social norms or migration)
Publication/ dissemination Comparative results from more then one European country raise a higher interest in the scientific community which enhances the publication of manuscripts in higher ranked journals.
Translation of research findings Findings from Europeanwide research consortia are well placed to contribute to Europeanwide policy with higher  probability of bringing about required change.
61
these consortia. Collectively, the challenges addressed an array 
of concerns. Broadly categorised, these included preparation, 
methodological, financial, operational, structural, ownership 
and dissemination challenges. However, during the process of 
categorizing the challenges, we often experienced ‘spill-overs’, 
where any particular challenge would have multi-pronged im-
plications. To cite an example, the issues of the stability of both 
the focus of the survey and the tool of the survey represent time-
factor (methodological) challenges in their own right. However 
these time-factor issues have ramifications as new partners join 
the consortium and new research areas are explored which then 
represent operational challenges. Further, as new partners join 
they require to be communicated and coordinated and the structure 
of the consortium might change to accommodate these new needs 
which then represent structural challenges. Finally as these new 
scientists settle, they would need to be acknowledged, included 
in the publication plan and dissemination outputs which then 
represent ownership and dissemination challenges. Thus, Table 
3 represents a simplification that does not take into account all 
possible scenarios and challenges.
The first set of challenges had to do with the preparatory work 
required before any multi-country study can commence. This 
included the selection of the topics of the research, as well as 
the issues surrounding the main aims of the proposed study (32). 
This set also included issues that were related “to not reinventing 
the wheel”, the planning of the research process, any present or 
likely future trends that could affect the research, as well as the 
choice of main working language of the consortium, and the need 
for early consultation with the potential stakeholders (3, 5). Solu-
tions included thorough literature reviews in order to determine 
health issues that require further investigation; the involvement 
of all consortium members in providing input on relevant top-
ics; and to obtain “buy in” from potential stakeholders early on. 
If there is not a common language that all consortium members 
can communicate in, it is essential to hire competent interpreters 
for meetings and conference calls. Equally important is to avoid 
domination by native or high proficient English speakers. 
The second set of queries was related to a broad range of 
methodological challenges. This set embraced issues of the as-
sessment instruments, sampling procedures and study protocols, 
Table 3. European Research consortia: some challenges and solutions
Challenge Example/ Implication Solutions
1. Preparatory work before the study
Focus and main aims 
of the study
Have the main aims of the study been determined by all consortium 
members? Why are comparisons between several countries useful? 
Are relevant future developments considered? What are the social and 
economic factors influencing health? Is the study innovative?
Review the international literature on students’ health. Agree 
on topics that have not been investigated so far.
Agree with all consortium members for input on relevant 
topics.
Planning of the 
research process
How will the study be financed? Will the study use quantitative or qualita-
tive methods or both? What is the best study design for the question/s 
posed? Which research instruments will be selected? 
Brainstorm funding sources and apply for funding, possibly from 
multiple sources. Agree on study design, research methodol-
ogy, and assessment instruments.
Language  
of consortium Is the consortium dominated by English-speaking members? Hire interpreters for meetings and conference calls. 
Consultation with 
potential stakeholders
Have all consortium members obtained “buy-in” from their administra-
tions and institutions? 
Communicate with the university administration and faculty 
members that are required to collaborate.
2. methodological challenges
Assessment instru-
ments (validity, 
reliability, translations, 
cultural issues, pilot 
testing)
What assessment instruments are available and in what languages? 
Are they psychometrically sound? Have back and forth translations 
been conducted? Can instruments capture country-specific features 
in spite of standardization? Have pilot tests been conducted in each 
participating country? Have some countries norms or laws that can 
result in underreporting (smoking, alcohol, drugs?)
When possible and appropriate, use instruments that have 
been validated in different languages. Verify that translations 
capture identical concepts. Discuss cultural aspects with 
consortium partners. Pilot assessment instruments in each 
country. Consider threat of underreporting when formulating 
questions.
Sampling
(institutions, faculties 
and students)
Are participating universities comparable across countries?
Are participating faculties comparable (health sciences, law, engineer-
ing, social sciences, theology etc)? Can the same sampling design be 
applied at all locations? Do the policies for attendance at lectures differ 
between universities? Are informants who choose to participate different 
from those who do not?
Use adequate sampling techniques, but selected institution/s 
must also be willing to participate. When data collection takes 
place during a course, record whether attendance of the course 
is mandatory. Specify eligibility criteria such as first/second year 
students, etc. Collect information about non-responders.
Ethical approval 
Are the regulations for conducting the study different across countries? 
What are the financial charges and time lines of ethics committees? 
Certain questions can be viewed unethical in some countries.
Satisfy requirements of ethics committees in each country. 
Committees could be more established/ stringent in some 
countries. Costs need to be budgeted.
Response rate 
(Standard procedures 
to calculate response 
rate; ways to increase 
response rate)
If data collection takes place in different settings, response rates 
may be determined using different methods. Have mechanisms been 
instilled to encourage high response rates? Is the respondent burden 
reasonable?
Clearly define what counts as non-response (blank or partly 
completed questionnaires, students leaving the room, students 
refusing to take a questionnaire). Provide informant incentives. 
Keep survey length reasonable. Provide time for completion 
during lectures. Choose responsible data collectors.
Confidentiality Is there a common protocol for data storage that guarantees confi-dentiality?
Protect confidentiality through separating names and identifiers 
or obtain data anonymously. 
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Data quality control 
and back-up
Is the data entry centralized or is it done at each country/institution? 
What are the procedures for quality control? Are there mechanisms for 
quality control before and after merging the individual country datasets? 
What are the protocols for making back-up copies?
If data entry takes place decentralised (i.e. at each research 
site), then standardise the procedures for data entry, cleaning 
and back-up. Data entry software that checks values and cross 
examines variables can prevent data entry errors.
Data access Is the dataset easily accessible for all the partners? Share data online (password protected) or by e-mail.
Data analyses 
(standardization, 
country comparisons, 
socio-economic data, 
homogeneity/stratifica-
tion,
innovative techniques, 
joint analysis)
Have the data analyses techniques been standardised across the 
participating countries? Can differences in outcomes be attributed 
to either the institution or the country? Cross-country comparisons of 
socio-economic data are difficult because of different monetary systems 
and cost of living. Are variables that pertain to the university collected? 
Does the impact of socio-economic data differ between countries? Are 
innovative statistical techniques needed? Are data homogenous enough 
for a joint analysis or meta-analysis?
Perform data analysis centrally or share data analysis tech-
niques, programs, and competencies. More than one university 
per country is needed to separate the effect of institutions 
and countries. Evaluate country-specific socio-economic 
data within countries, ad relative rankings between countries. 
Perform stratified analysis/analysis of interactions with country 
as a variable. Complex modelling using either Bayesian ap-
proach or structural modelling equations may be necessary. 
Prospectively planned pooled analysis is more flexible than 
formal meta-analysis.
Time factor 
(secular trends; loss 
on follow-up; changing 
focus of study, assess-
ment tools, investiga-
tors)
Have secular trends in each country been considered in order that the 
‘net’ effects can be isolated? Can students be re-contacted for follow-
up assessments? Did the focus of the survey change due to emerging 
interests in the scientific community (e.g., more focus on smoking in later 
surveys)? Did the assessment tool remain constant or was it modified 
based on knowledge gained from earlier work? Have some researchers 
left while others with new interests joined the consortium?
Estimate secular trends for longitudinal studies and cross-
sectional studies that take place in different years.
If feasible, collect participant´s home address, registration 
number, and e-mail/s. Carefully assess the cost-benefit of 
amending the focus of the survey. Carefully assess the cost-
benefit of modifying the survey and consider leaving some 
“core items” unchanged.
3. Financial Challenges
General finances Have proposals been submitted to obtain funding for a cross-national study that is unlikely to be funded by one country only?
Apply for European funding for the whole consortium; smaller 
grants for individual countries and institutions.
Funding of joint scien-
tific activities
Are research activities planned and conducted jointly in a coordinated 
fashion? Secure adequate funding for joint scientific activities.
Adequate funding: 
individual countries
What are the salary scales for researchers in countries with less eco-
nomic resources (e.g. Eastern Europe)?
Low salaries affect the quality of researchers who are recruited 
in some countries.
Unequal resources Are there sufficient resources (equipment) across countries? Allocate additional resources in the planning stage.
Fiscal/ tax years Do participating countries have identical tax years? Are there long waiting periods before actual allocation of resources?
Consider these issues to facilitate the smooth flow of funds 
across countries and funding agencies.
4. Operational challenges: partnership working of research consortia
Planning Have joint activities been planned across the participating countries? Plan joint activities proactively rather than reactively.
Participation
(Division of labour and 
decision making)
Do all consortium members actively participate? Is the workload 
adequately distributed? Are organisational, operational and scientific 
issues democratically decided upon?
All consortium members need to have the interest and capacity 
to participate. Workload needs to be distributed fairly, decision 
making should not ‘choke’ activities.
Relationships between 
members
Are relationships between members actively maintained? Are new 
members welcomed into the consortium? 
Plan regular work meetings and conference calls. Introduce 
research activities to new members. 
5. Structural challenges: the shape of the consortium
Management, coordi-
nation and communi-
cation
Is the consortium professionally managed? 
Who is responsible for initiating and documenting communications 
between the partners? 
Set up regular meetings and conference calls, distribute 
minutes, agree on and enforce action points and timelines. 
Specify responsibilities for coordinating center(s).
Leadership Is there a competent and adequately resourced leadership established? Are tasks and responsibilities clearly defined?
Consortia need sound leadership with adequate support and 
leadership skills
6. Ownership and dissemination challenges
Acknowledgement How are consortia members and funding agencies acknowledged? All members agree on acknowledgment paragraph.
Ownership of data Who owns data from individual institutions, countries or the whole consortium? 
All members agree on rules that clarify who has the right to 
analyse which datasets. 
Publications How do members plan publications? 
All members agree on outlines provided by lead authors prior 
to manuscript preparation to prevent conflicts and duplication 
of analyses. 
Authorship How is authorship decided?
Authorship issues are deliberated early and be premised on 
contributions as per international requirements for author-
ship.
Dissemination  
channel/s
Do the targeted journal/s consider manuscripts with more than 6 au-
thors? Do these journals agree to an acknowledgment paragraph that 
would acknowledge the rest of the team?
Lead authors agree on contacting the journals to be targeted for 
dissemination prior to manuscript preparation. Journals need 
to accommodate the multi-authorship nature of manuscripts 
from research consortia
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as well as data access, analysis, and the time factor (time-sensitive 
issues) which need to be considered when conducting longitudinal 
studies. Some of the issues in this set related to the psychometric 
properties of the assessment tools in terms of validity and reli-
ability, in addition to the piloting of instruments in the appropriate 
languages. The translation of assessment instruments is a major 
methodological challenge for European research consortia. 
Translation methods need to be employed that aim to establish 
equivalence of meaning (36) and the assessment of the same 
attributes in each cultural group or country (37). Cross-cultural 
and cross-language equivalence require attention and need to be 
assessed in instrument translation (38). Yet most existing cross 
cultural research does not adequately describe translation methods 
that are used (4).
Further methodological concerns focussed on the need for 
standardised sampling schemes across the participating countries. 
The participating institutions and students of each country should 
preferably also be fairly representative of the countries they origi-
nate from if findings are to be generalisable. In addition, this set 
also revealed concerns in relation to requirements for the ethical 
approval of the study, which may vary in different countries (3, 
39–41). There are legitimate concerns about the confidentiality 
of the participants’ and universities’ collected data that need to 
be addressed (5).
Additionally, many other assorted methodological challenges 
need consideration by consortia who aim to research similar 
issues across multiple organisations or countries. For example 
when surveys are implemented over several years or when fol-
low-up surveys of particular cohorts are intended in order to 
understand short-term or long-term effects, the time factor needs 
to be considered. Within this realm, the challenges included the 
possibility of secular trends, the losses to follow-up, as well as 
some ‘stability’ issues that are critical in longitudinal research: 
the stability of the focus of the study, the assessment tools, and 
the researcher team (42).
Furthermore, this set of methodological challenges also includ-
ed a variety of features related to the analyses of the emergent data 
sets. These comprised the statistical techniques to be employed; 
the use of multilevel analysis and stratification; the importance of 
inclusion in the survey of institution-specific variables in order to 
contrast institutions; as well as the appropriateness of attributing 
any effect/s to either the characteristics of the specific institution 
or the country. Some particular suggestions for dealing with these 
challenges are provided in Table 3. 
The third set of difficulties had to do with the financial aspects 
of research consortia. These comprised the availability of suffi-
cient funding and whether such funding is likely to be Pan-Euro-
pean or country specific; the flow of finances between countries 
and institutions; and whether participating countries have compat-
ible or opposing fiscal years. In addition, other concerns were in 
relation to whether there is adequate budgeting and provision for 
joint scientific activities and meetings; the challenges associated 
with different rules and regulations governing the salary scales 
for researchers in countries with different economic development; 
and the thorny issue of unequal access to material resources such 
as hardware and software or human resources (5, 9, 43, 44).
The fourth set of potential obstacles was related to the op-
erational challenges that are encountered in the collaborative 
nature of research consortia. These included issues of careful 
planning of joint activities, good participation by all members 
of the consortium, fair division of labour, democratic decision 
making, the building of relationships and sustaining them, as well 
as the integration of new partners as the research consortium is 
expanding (45). Collaborators in a research consortium rarely 
assess the process of collaboration (5) and partnership working 
(46) that usually requires the assessment of the multiple facets 
of the collaborative practice (1, 47).
The fifth set of complexities had to do with the structural chal-
lenges as regards the ‘shape’ of the consortium. These included 
a range of management, coordination and communication issues 
as well as leadership. Problems of communication are not uncom-
mon (48–50) and could generate misunderstandings, as well as 
failures to appreciate important differences among the partici-
pating sites (5). Thus, consortia need to set up regular meetings, 
conference calls, and e-mail contacts, distribute minutes, and 
agree on and enforce action points and time lines. 
Finally, the sixth set of challenges was related to the equitable 
ownership of data or the unbiased sharing of opportunities for 
new projects and peer-reviewed dissemination (5). These included 
queries on who owned which data, whether different datasets were 
comparable, as well as issues around the planned published out-
puts and its accompanying plan of authorship. There needs to be 
agreed rules that clarify data ownership and outline the process of 
manuscript development and authorship issues early on to clarify 
expectations, avoid conflicts and duplication of analyses. 
CoNClUSIoN
Consortia are increasingly employed for clinical and public 
health research. Therefore, a discussion of benefits, challenges, 
and solutions may assist in planning and implementing such 
research collaborations. This paper has contributed to a more 
comprehensive understanding of the complexities surrounding 
the work of research consortia. Cross-national consortia can play 
a role in the reduction in the inequality of resources and research 
opportunities in the participating countries. However, there are 
difficulties surrounding the work of consortia that collaborate 
on conducting research across several sites (3, 5, 6, 8, 9, 31, 51, 
53). Countries have different languages, traditions of academic 
cultures and hierarchies, dissimilar rules, regulations and ethical 
requirements, as well as distinct tax years and personnel recruit-
ment policies. All these challenges and many others will need to 
be systematically considered and thoroughly addressed in order 
that a research consortium is fruitful and productive. Authors of 
this review may have not been aware of additional challenges 
which aroused in projects undertaken by others. Furthermore, the 
challenges can increase when worldwide research activities are in-
volved, with more countries participating in the investigations.
Nevertheless, if these anticipated challenges are prevented 
or solved, the benefits of research consortia can include greater 
generalisability of findings, a more comprehensive appreciation of 
the study results than would be possible with a single-site inquiry, 
and increased probabilities to bring about policy changes. Cross-
national research consortia can reduce the inequality of resources 
and research opportunities. Such consortia deserve the attention 
of funding agencies and research councils. They have a great 
potential for synergies that result from the collaborating together 
64
of large multi-disciplinary investigator teams sharing their diverse 
strengths and expertise, all working on the same research issue 
in multiple countries and diverse populations. 
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GloBal Goal To REDUCE MEaSlES DEaTHS IN 
CHIlDREN SURPaSSED
Measles deaths fall by 60 per cent
NEW YoRK/GENEVa, 19 January 2007 – Measles deaths 
have fallen by 60 per cent worldwide since 1999 – a major public 
health success. This exceeds the United Nations goal to halve 
measles deaths between 1999 and 2005 and is largely due to an 
unprecedented decline in measles deaths in the African region.  The 
progress was announced today by partners in the Measles Initiative: 
the American Red Cross, the United States Centers for Disease 
Control and Prevention (CDC), the United Nations Foundation, 
UNICEF and the World Health Organization (WHO.
According to new data from WHO, global measles deaths fell 
from an estimated 873,000 deaths in 1999 to 345,000 in 2005. In 
Africa, the progress has been even greater, with measles deaths 
falling by 75 per cent, from an estimated 506,000 to 126,000. The 
data will be published in this week’s edition of The Lancet. 
“This is an historic victory for global public health, for the 
power of partnership and for commitment by countries to fight a 
terrible disease,” said Dr. Margaret Chan, WHO Director-General. 
“Our promise to cut measles deaths by half and save hundreds of 
thousands of lives has not only been fulfilled, it has been surpassed 
in just six years with Africa leading the way.”
The 75 per cent reduction in measles deaths in Africa is due to 
the firm commitment and resources of national governments, and 
support from the Measles Initiative.  It is described as “a spectacu-
lar achievement,” by Mr. U Olanguena Awono, Minister of Public 
Health, Cameroon. “We are winning the fight against measles, 
which has long killed, sickened and disabled our children.  Our de-
termination is stronger than ever to make measles history by further 
strengthening our measles control activities, working in concert 
with our international partners and setting aside resources.”
A strategy to reduce measles mortality, consisting of four com-
ponents, has been key to ensuring the massive global decrease in 
measles deaths. The strategy calls for the provision of one dose 
of measles vaccine for all infants via routine health services; a 
second opportunity for measles immunization for all children, 
generally through mass vaccination campaigns; effective surveil-
lance for measles; and enhanced care, including the provision of 
supplemental vitamin A.
As a result of this strategy, between 1999 and 2005 global 
measles immunization coverage with the first routine dose in-
creased from 71 per cent to 77 per cent, and more than 360 mil-
lion children aged 9 months to 15 years received measles vaccine 
through immunization campaigns. 
“One of the clearest messages from this achievement is that with 
the right strategies and a strong partnership of committed govern-
ments and organizations, you can rapidly reduce child deaths in 
developing countries,” said Dr. Julie Gerberding, Director, United 
States Centers for Disease Control and Prevention (CDC). 
Accelerated measles control activities are contributing to the 
development of health infrastructure to support routine immuniza-
tion and other health services through promotion of safe injection 
practices, increased ‘cold chain’ capacity for vaccines storage, and 
the development of a global public health laboratory network.
In addition, measles vaccination campaigns are contributing to 
the reduction of child deaths from other causes. They have become 
a channel for the delivery of other life-saving interventions, such 
as bed nets to protect against malaria, de-worming medicine and 
vitamin A supplements. Combining measles immunization with 
other health interventions is a contribution to the achievement of 
Millennium Development Goal Number 4: a two-thirds reduction 
in child deaths between 1990 and 2015.
“Reducing measles deaths by 60 per cent in just six years is an 
incredible achievement,” said UNICEF Executive Director, Ann 
M. Veneman. “Immunizing children is clearly saving lives and 
contributing to the achievement of the Millennium Development 
Goals. We must urgently build on this momentum with integrated 
community-based health programmes to help save the lives of 
the over 10 million children who die of preventable causes every 
year.”
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